Baystreet Staff - Friday, April 18, 2008 PharmaGap Inc. 12:11 PM EST - PharmaGap Inc. : shares were down 18 percent after rocketing up 50 cents or 455 percent Thursday on word of positive animal studies on its lead cancer drug. PharmaGap Inc. shares V.GAP are trading down 11 cents at $0.50.